The global Tumor Biomarker Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Tumor Biomarker Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tumor Biomarker Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Tumor Biomarker Test in Lung cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Tumor Biomarker Test include Abbott Laboratories, Inc., Agilent Technologies, AstraZeneca, Becton Dickinson & Co., Biocept Inc., Cancer Genetics Inc., Danaher Corporation, Foundation Medicine Inc. and Illumina Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tumor Biomarker Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Biomarker Test.

Report Scope

The Tumor Biomarker Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Biomarker Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tumor Biomarker Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tumor Biomarker Test Market Report

Report Metric	Details
Report Name	Tumor Biomarker Test Market
Segment by Type	Prostate Specific Antigen Tests CTC Tests Alpha-Fetoprotein (AFP) Tests CA Test HER2 Tests BRCA Test Anaplastic Lymphoma Kinase (ALK) Tests EGFR Mutation Tests KRAS Test Others
Segment by Application	Lung cancer Breast cancer Colorectal Prostate Cancer Blood Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Inc., Agilent Technologies, AstraZeneca, Becton Dickinson & Co., Biocept Inc., Cancer Genetics Inc., Danaher Corporation, Foundation Medicine Inc., Illumina Inc., LabCorp Of America Holdings, Luminex Corporation, Myriad Genetics Inc., NanoString Technologies Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Biomarker Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor Biomarker Test Market report?

Ans: The main players in the Tumor Biomarker Test Market are Abbott Laboratories, Inc., Agilent Technologies, AstraZeneca, Becton Dickinson & Co., Biocept Inc., Cancer Genetics Inc., Danaher Corporation, Foundation Medicine Inc., Illumina Inc., LabCorp Of America Holdings, Luminex Corporation, Myriad Genetics Inc., NanoString Technologies Inc.

What are the Application segmentation covered in the Tumor Biomarker Test Market report?

Ans: The Applications covered in the Tumor Biomarker Test Market report are Lung cancer, Breast cancer, Colorectal, Prostate Cancer, Blood Cancer

What are the Type segmentation covered in the Tumor Biomarker Test Market report?

Ans: The Types covered in the Tumor Biomarker Test Market report are Prostate Specific Antigen Tests, CTC Tests, Alpha-Fetoprotein (AFP) Tests, CA Test, HER2 Tests, BRCA Test, Anaplastic Lymphoma Kinase (ALK) Tests, EGFR Mutation Tests, KRAS Test, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tumor Biomarker Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Prostate Specific Antigen Tests

1.2.3 CTC Tests

1.2.4 Alpha-Fetoprotein (AFP) Tests

1.2.5 CA Test

1.2.6 HER2 Tests

1.2.7 BRCA Test

1.2.8 Anaplastic Lymphoma Kinase (ALK) Tests

1.2.9 EGFR Mutation Tests

1.2.10 KRAS Test

1.2.11 Others

1.3 Market by Application

1.3.1 Global Tumor Biomarker Test Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Lung cancer

1.3.3 Breast cancer

1.3.4 Colorectal

1.3.5 Prostate Cancer

1.3.6 Blood Cancer

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tumor Biomarker Test Market Perspective (2019-2030)

2.2 Tumor Biomarker Test Growth Trends by Region

2.2.1 Global Tumor Biomarker Test Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Tumor Biomarker Test Historic Market Size by Region (2019-2024)

2.2.3 Tumor Biomarker Test Forecasted Market Size by Region (2025-2030)

2.3 Tumor Biomarker Test Market Dynamics

2.3.1 Tumor Biomarker Test Industry Trends

2.3.2 Tumor Biomarker Test Market Drivers

2.3.3 Tumor Biomarker Test Market Challenges

2.3.4 Tumor Biomarker Test Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tumor Biomarker Test Players by Revenue

3.1.1 Global Top Tumor Biomarker Test Players by Revenue (2019-2024)

3.1.2 Global Tumor Biomarker Test Revenue Market Share by Players (2019-2024)

3.2 Global Tumor Biomarker Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Tumor Biomarker Test Revenue

3.4 Global Tumor Biomarker Test Market Concentration Ratio

3.4.1 Global Tumor Biomarker Test Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tumor Biomarker Test Revenue in 2023

3.5 Tumor Biomarker Test Key Players Head office and Area Served

3.6 Key Players Tumor Biomarker Test Product Solution and Service

3.7 Date of Enter into Tumor Biomarker Test Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Biomarker Test Breakdown Data by Type

4.1 Global Tumor Biomarker Test Historic Market Size by Type (2019-2024)

4.2 Global Tumor Biomarker Test Forecasted Market Size by Type (2025-2030)

5 Tumor Biomarker Test Breakdown Data by Application

5.1 Global Tumor Biomarker Test Historic Market Size by Application (2019-2024)

5.2 Global Tumor Biomarker Test Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Tumor Biomarker Test Market Size (2019-2030)

6.2 North America Tumor Biomarker Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Tumor Biomarker Test Market Size by Country (2019-2024)

6.4 North America Tumor Biomarker Test Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tumor Biomarker Test Market Size (2019-2030)

7.2 Europe Tumor Biomarker Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Tumor Biomarker Test Market Size by Country (2019-2024)

7.4 Europe Tumor Biomarker Test Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tumor Biomarker Test Market Size (2019-2030)

8.2 Asia-Pacific Tumor Biomarker Test Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Tumor Biomarker Test Market Size by Region (2019-2024)

8.4 Asia-Pacific Tumor Biomarker Test Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tumor Biomarker Test Market Size (2019-2030)

9.2 Latin America Tumor Biomarker Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Tumor Biomarker Test Market Size by Country (2019-2024)

9.4 Latin America Tumor Biomarker Test Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tumor Biomarker Test Market Size (2019-2030)

10.2 Middle East & Africa Tumor Biomarker Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Tumor Biomarker Test Market Size by Country (2019-2024)

10.4 Middle East & Africa Tumor Biomarker Test Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories, Inc.

11.1.1 Abbott Laboratories, Inc. Company Detail

11.1.2 Abbott Laboratories, Inc. Business Overview

11.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Introduction

11.1.4 Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2019-2024)

11.1.5 Abbott Laboratories, Inc. Recent Development

11.2 Agilent Technologies

11.2.1 Agilent Technologies Company Detail

11.2.2 Agilent Technologies Business Overview

11.2.3 Agilent Technologies Tumor Biomarker Test Introduction

11.2.4 Agilent Technologies Revenue in Tumor Biomarker Test Business (2019-2024)

11.2.5 Agilent Technologies Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Detail

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Tumor Biomarker Test Introduction

11.3.4 AstraZeneca Revenue in Tumor Biomarker Test Business (2019-2024)

11.3.5 AstraZeneca Recent Development

11.4 Becton Dickinson & Co.

11.4.1 Becton Dickinson & Co. Company Detail

11.4.2 Becton Dickinson & Co. Business Overview

11.4.3 Becton Dickinson & Co. Tumor Biomarker Test Introduction

11.4.4 Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2019-2024)

11.4.5 Becton Dickinson & Co. Recent Development

11.5 Biocept Inc.

11.5.1 Biocept Inc. Company Detail

11.5.2 Biocept Inc. Business Overview

11.5.3 Biocept Inc. Tumor Biomarker Test Introduction

11.5.4 Biocept Inc. Revenue in Tumor Biomarker Test Business (2019-2024)

11.5.5 Biocept Inc. Recent Development

11.6 Cancer Genetics Inc.

11.6.1 Cancer Genetics Inc. Company Detail

11.6.2 Cancer Genetics Inc. Business Overview

11.6.3 Cancer Genetics Inc. Tumor Biomarker Test Introduction

11.6.4 Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2019-2024)

11.6.5 Cancer Genetics Inc. Recent Development

11.7 Danaher Corporation

11.7.1 Danaher Corporation Company Detail

11.7.2 Danaher Corporation Business Overview

11.7.3 Danaher Corporation Tumor Biomarker Test Introduction

11.7.4 Danaher Corporation Revenue in Tumor Biomarker Test Business (2019-2024)

11.7.5 Danaher Corporation Recent Development

11.8 Foundation Medicine Inc.

11.8.1 Foundation Medicine Inc. Company Detail

11.8.2 Foundation Medicine Inc. Business Overview

11.8.3 Foundation Medicine Inc. Tumor Biomarker Test Introduction

11.8.4 Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2019-2024)

11.8.5 Foundation Medicine Inc. Recent Development

11.9 Illumina Inc.

11.9.1 Illumina Inc. Company Detail

11.9.2 Illumina Inc. Business Overview

11.9.3 Illumina Inc. Tumor Biomarker Test Introduction

11.9.4 Illumina Inc. Revenue in Tumor Biomarker Test Business (2019-2024)

11.9.5 Illumina Inc. Recent Development

11.10 LabCorp Of America Holdings

11.10.1 LabCorp Of America Holdings Company Detail

11.10.2 LabCorp Of America Holdings Business Overview

11.10.3 LabCorp Of America Holdings Tumor Biomarker Test Introduction

11.10.4 LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2019-2024)

11.10.5 LabCorp Of America Holdings Recent Development

11.11 Luminex Corporation

11.11.1 Luminex Corporation Company Detail

11.11.2 Luminex Corporation Business Overview

11.11.3 Luminex Corporation Tumor Biomarker Test Introduction

11.11.4 Luminex Corporation Revenue in Tumor Biomarker Test Business (2019-2024)

11.11.5 Luminex Corporation Recent Development

11.12 Myriad Genetics Inc.

11.12.1 Myriad Genetics Inc. Company Detail

11.12.2 Myriad Genetics Inc. Business Overview

11.12.3 Myriad Genetics Inc. Tumor Biomarker Test Introduction

11.12.4 Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2019-2024)

11.12.5 Myriad Genetics Inc. Recent Development

11.13 NanoString Technologies Inc.

11.13.1 NanoString Technologies Inc. Company Detail

11.13.2 NanoString Technologies Inc. Business Overview

11.13.3 NanoString Technologies Inc. Tumor Biomarker Test Introduction

11.13.4 NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2019-2024)

11.13.5 NanoString Technologies Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott Laboratories Inc

Foundation Medicine, Inc

Illumina Inc

LabCorp Of America Holdings

Luminex Corporation

Myriad Genetics Inc

NanoString Technologies, Inc.

List of Tables

Table 1. Global Tumor Biomarker Test Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Prostate Specific Antigen Tests

Table 3. Key Players of CTC Tests

Table 4. Key Players of Alpha-Fetoprotein (AFP) Tests

Table 5. Key Players of CA Test

Table 6. Key Players of HER2 Tests

Table 7. Key Players of BRCA Test

Table 8. Key Players of Anaplastic Lymphoma Kinase (ALK) Tests

Table 9. Key Players of EGFR Mutation Tests

Table 10. Key Players of KRAS Test

Table 11. Key Players of Others

Table 12. Global Tumor Biomarker Test Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 13. Global Tumor Biomarker Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 14. Global Tumor Biomarker Test Market Size by Region (2019-2024) & (US$ Million)

Table 15. Global Tumor Biomarker Test Market Share by Region (2019-2024)

Table 16. Global Tumor Biomarker Test Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 17. Global Tumor Biomarker Test Market Share by Region (2025-2030)

Table 18. Tumor Biomarker Test Market Trends

Table 19. Tumor Biomarker Test Market Drivers

Table 20. Tumor Biomarker Test Market Challenges

Table 21. Tumor Biomarker Test Market Restraints

Table 22. Global Tumor Biomarker Test Revenue by Players (2019-2024) & (US$ Million)

Table 23. Global Tumor Biomarker Test Market Share by Players (2019-2024)

Table 24. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Biomarker Test as of 2023)

Table 25. Ranking of Global Top Tumor Biomarker Test Companies by Revenue (US$ Million) in 2023

Table 26. Global 5 Largest Players Market Share by Tumor Biomarker Test Revenue (CR5 and HHI) & (2019-2024)

Table 27. Key Players Headquarters and Area Served

Table 28. Key Players Tumor Biomarker Test Product Solution and Service

Table 29. Date of Enter into Tumor Biomarker Test Market

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Tumor Biomarker Test Market Size by Type (2019-2024) & (US$ Million)

Table 32. Global Tumor Biomarker Test Revenue Market Share by Type (2019-2024)

Table 33. Global Tumor Biomarker Test Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 34. Global Tumor Biomarker Test Revenue Market Share by Type (2025-2030)

Table 35. Global Tumor Biomarker Test Market Size by Application (2019-2024) & (US$ Million)

Table 36. Global Tumor Biomarker Test Revenue Market Share by Application (2019-2024)

Table 37. Global Tumor Biomarker Test Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 38. Global Tumor Biomarker Test Revenue Market Share by Application (2025-2030)

Table 39. North America Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. North America Tumor Biomarker Test Market Size by Country (2019-2024) & (US$ Million)

Table 41. North America Tumor Biomarker Test Market Size by Country (2025-2030) & (US$ Million)

Table 42. Europe Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Tumor Biomarker Test Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Tumor Biomarker Test Market Size by Country (2025-2030) & (US$ Million)

Table 45. Asia-Pacific Tumor Biomarker Test Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 46. Asia-Pacific Tumor Biomarker Test Market Size by Region (2019-2024) & (US$ Million)

Table 47. Asia-Pacific Tumor Biomarker Test Market Size by Region (2025-2030) & (US$ Million)

Table 48. Latin America Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Latin America Tumor Biomarker Test Market Size by Country (2019-2024) & (US$ Million)

Table 50. Latin America Tumor Biomarker Test Market Size by Country (2025-2030) & (US$ Million)

Table 51. Middle East & Africa Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 52. Middle East & Africa Tumor Biomarker Test Market Size by Country (2019-2024) & (US$ Million)

Table 53. Middle East & Africa Tumor Biomarker Test Market Size by Country (2025-2030) & (US$ Million)

Table 54. Abbott Laboratories, Inc. Company Detail

Table 55. Abbott Laboratories, Inc. Business Overview

Table 56. Abbott Laboratories, Inc. Tumor Biomarker Test Product

Table 57. Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 58. Abbott Laboratories, Inc. Recent Development

Table 59. Agilent Technologies Company Detail

Table 60. Agilent Technologies Business Overview

Table 61. Agilent Technologies Tumor Biomarker Test Product

Table 62. Agilent Technologies Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 63. Agilent Technologies Recent Development

Table 64. AstraZeneca Company Detail

Table 65. AstraZeneca Business Overview

Table 66. AstraZeneca Tumor Biomarker Test Product

Table 67. AstraZeneca Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 68. AstraZeneca Recent Development

Table 69. Becton Dickinson & Co. Company Detail

Table 70. Becton Dickinson & Co. Business Overview

Table 71. Becton Dickinson & Co. Tumor Biomarker Test Product

Table 72. Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 73. Becton Dickinson & Co. Recent Development

Table 74. Biocept Inc. Company Detail

Table 75. Biocept Inc. Business Overview

Table 76. Biocept Inc. Tumor Biomarker Test Product

Table 77. Biocept Inc. Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 78. Biocept Inc. Recent Development

Table 79. Cancer Genetics Inc. Company Detail

Table 80. Cancer Genetics Inc. Business Overview

Table 81. Cancer Genetics Inc. Tumor Biomarker Test Product

Table 82. Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 83. Cancer Genetics Inc. Recent Development

Table 84. Danaher Corporation Company Detail

Table 85. Danaher Corporation Business Overview

Table 86. Danaher Corporation Tumor Biomarker Test Product

Table 87. Danaher Corporation Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 88. Danaher Corporation Recent Development

Table 89. Foundation Medicine Inc. Company Detail

Table 90. Foundation Medicine Inc. Business Overview

Table 91. Foundation Medicine Inc. Tumor Biomarker Test Product

Table 92. Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 93. Foundation Medicine Inc. Recent Development

Table 94. Illumina Inc. Company Detail

Table 95. Illumina Inc. Business Overview

Table 96. Illumina Inc. Tumor Biomarker Test Product

Table 97. Illumina Inc. Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 98. Illumina Inc. Recent Development

Table 99. LabCorp Of America Holdings Company Detail

Table 100. LabCorp Of America Holdings Business Overview

Table 101. LabCorp Of America Holdings Tumor Biomarker Test Product

Table 102. LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 103. LabCorp Of America Holdings Recent Development

Table 104. Luminex Corporation Company Detail

Table 105. Luminex Corporation Business Overview

Table 106. Luminex Corporation Tumor Biomarker Test Product

Table 107. Luminex Corporation Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 108. Luminex Corporation Recent Development

Table 109. Myriad Genetics Inc. Company Detail

Table 110. Myriad Genetics Inc. Business Overview

Table 111. Myriad Genetics Inc. Tumor Biomarker Test Product

Table 112. Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 113. Myriad Genetics Inc. Recent Development

Table 114. NanoString Technologies Inc. Company Detail

Table 115. NanoString Technologies Inc. Business Overview

Table 116. NanoString Technologies Inc. Tumor Biomarker Test Product

Table 117. NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2019-2024) & (US$ Million)

Table 118. NanoString Technologies Inc. Recent Development

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tumor Biomarker Test Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Tumor Biomarker Test Market Share by Type: 2023 VS 2030

Figure 3. Prostate Specific Antigen Tests Features

Figure 4. CTC Tests Features

Figure 5. Alpha-Fetoprotein (AFP) Tests Features

Figure 6. CA Test Features

Figure 7. HER2 Tests Features

Figure 8. BRCA Test Features

Figure 9. Anaplastic Lymphoma Kinase (ALK) Tests Features

Figure 10. EGFR Mutation Tests Features

Figure 11. KRAS Test Features

Figure 12. Others Features

Figure 13. Global Tumor Biomarker Test Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 14. Global Tumor Biomarker Test Market Share by Application: 2023 VS 2030

Figure 15. Lung cancer Case Studies

Figure 16. Breast cancer Case Studies

Figure 17. Colorectal Case Studies

Figure 18. Prostate Cancer Case Studies

Figure 19. Blood Cancer Case Studies

Figure 20. Tumor Biomarker Test Report Years Considered

Figure 21. Global Tumor Biomarker Test Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 22. Global Tumor Biomarker Test Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 23. Global Tumor Biomarker Test Market Share by Region: 2023 VS 2030

Figure 24. Global Tumor Biomarker Test Market Share by Players in 2023

Figure 25. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Biomarker Test as of 2023)

Figure 26. The Top 10 and 5 Players Market Share by Tumor Biomarker Test Revenue in 2023

Figure 27. North America Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. North America Tumor Biomarker Test Market Share by Country (2019-2030)

Figure 29. United States Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Canada Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Europe Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Europe Tumor Biomarker Test Market Share by Country (2019-2030)

Figure 33. Germany Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. France Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. U.K. Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Italy Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Russia Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Nordic Countries Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Asia-Pacific Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Asia-Pacific Tumor Biomarker Test Market Share by Region (2019-2030)

Figure 41. China Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Japan Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Latin America Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Latin America Tumor Biomarker Test Market Share by Country (2019-2030)

Figure 49. Mexico Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Brazil Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Tumor Biomarker Test Market Share by Country (2019-2030)

Figure 53. Turkey Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Tumor Biomarker Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Abbott Laboratories, Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 56. Agilent Technologies Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 57. AstraZeneca Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 58. Becton Dickinson & Co. Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 59. Biocept Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 60. Cancer Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 61. Danaher Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 62. Foundation Medicine Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 63. Illumina Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 64. LabCorp Of America Holdings Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 65. Luminex Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 66. Myriad Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 67. NanoString Technologies Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Tumor Biomarker Test Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-3E3424

Global Tumor Biomarker Test Market Research Report 2024

FEATURED COMPANIES

Tumor Biomarker Test Market

Report Scope

Scope of Tumor Biomarker Test Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Tumor Biomarker Test Market report?

What are the Application segmentation covered in the Tumor Biomarker Test Market report?

What are the Type segmentation covered in the Tumor Biomarker Test Market report?

FEATURED COMPANIES

Global Intraoperative Neuromonitoring IONM Devices Industry Research Report Growth Trends and Competitive Analysis 2022 2028

Single User, Electronic (PDF)

Global Large Language Model LLM Market Research Report 2023

Single User, Electronic (PDF)